|
JK184
|
N-(4-乙氧基苯基)-4-(2-甲基咪唑并[1,2-A]吡啶-3-基)噻唑-2-胺
|
315703-52-7
|
|
Taladegib
|
4-氟-N-甲基-N-[1-[4-(1-甲基-1H-吡唑-5-基)-1-酞嗪基]-4-哌啶基]-2-(三氟甲基)苯甲酰胺
|
1258861-20-9
|
|
SAR407899 hydrochloride
|
6-(哌啶-4-氧基)异喹啉-1(2H)-酮盐酸盐
|
923262-96-8
|
|
SAR407899
|
SAR407899
|
923359-38-0
|
|
Tegatrabetan
|
1227637-23-1
|
1227637-23-1
|
|
ETC-159
|
1,2,3,6-四氢-1,3-二甲基-2,6-二氧代-N-(6-苯基-3-哒嗪基)-7H-嘌呤-7-乙酰胺
|
1638250-96-0
|
|
FzM1.8
|
Fzd4 agonist FzM1.8)
|
2204290-85-5
|
|
IWP-O1
|
IWP-O1
|
2074607-48-8
|
|
β-catenin-IN-2
|
β-catenin-IN-2
|
1458664-10-2
|
|
Y-27632
|
Y-27632二盐酸盐
|
146986-50-7
|
|
TBCA
|
Casein Kinase II Inhibitor III
|
934358-00-6
|
|
IWP-2
|
IWP-2
|
686770-61-6
|
|
CGP77675
|
CGP 77675; CGP-77675
|
234772-64-6
|
|
Chroman 1
|
(3S)-N-[2-[2-(二甲基氨基)乙氧基]-4-(1H-吡唑-4-基)苯基]-3,4-二氢-6-甲氧基-2H-1-苯并吡喃-3-甲酰胺
|
1273579-40-0
|
|
Wnt pathway activator 1
|
1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-4-phenylbutane-1,4-dione
|
1360540-81-3
|
|
LF3
|
LF3
|
664969-54-4
|
|
BDP5290
|
BDP5290
|
1817698-21-7
|
|
Casein Kinase II Inhibitor IV
|
863598-09-8
|
863598-09-8
|
|
RU-SKI 43 hydrochloride
|
RU-SKI 43 HCL;HHAT INHIBITOR
|
1782573-67-4
|
|
YAP/TAZ inhibitor-1
|
2-((4,4-dimethylcyclohexyl)sulfonyl)-7-((4-(1-phenylethyl)piperazin-1-yl)sulfonyl)-9H-fluoren-9-one oxime
|
2093565-23-0
|
|
FIDAS-5
|
FIDAS-5
|
1391934-98-7
|
|
I3MT-3
|
4(3H)-Pyrimidinone, 6-methyl-2-[[2-(1-naphthalenyl)-2-oxoethyl]thio]-
|
459420-09-8
|
|
NCC007
|
NCC007游离态
|
2342583-66-6
|
|
SANT-1
|
SANT1
|
304909-07-7
|
|
Prinaberel
|
普林贝瑞
|
524684-52-4
|
|
Saridegib
|
IPI-926
|
1037210-93-7
|
|
Emodin
|
大黄素
|
518-82-1
|
|
Ciliobrevin D
|
Cilliobrevin D
|
1370554-01-0
|
|
Adavivint
|
SM04690
|
1467093-03-3
|
|
LEQ506
|
1204975-42-7
|
1204975-42-7
|
|
MRT00033659
|
MRT00033659
|
1401731-54-1
|
|
HSD1590
|
|
2379279-96-4
|
|
CUR61414
|
CUR 61414
|
334998-36-6
|
|
ICG-001
|
ICG-001
|
780757-88-2
|
|
Neurodazine
|
2-[5-(3-Chlorophenyl)-2-furanyl]-4,5-bis(4-methoxyphenyl)-1H-imidazole
|
937807-66-4
|
|
Y-33075 dihydrochloride
|
Y39983 HYDROCHLORIDE
|
173897-44-4
|
|
WAY-262611
|
MAY-262611
|
1123231-07-1
|
|
Verosudil
|
VEROSUDIL
|
1414854-42-4
|
|
CCT251545
|
CCT251545
|
1661839-45-7
|
|
GNF-6231
|
GNF6231
|
1243245-18-2
|
|
SKL2001
|
SKL2001
|
909089-13-0
|
|
DDR Inhibitor
|
1644069-80-6
|
1644069-80-6
|
|
DK419
|
DK419
|
2102672-22-8
|
|
ROCK inhibitor-2
|
ROCK inhibitor-2
|
1127308-52-4
|
|
Bevacizumab
|
贝伐珠单抗
|
216974-75-3
|
|
LX7101
|
LX7101
|
1192189-69-7
|
|
BMS-833923
|
BMS-833923
|
1059734-66-5
|
|
Sonidegib diphosphate
|
SONIDEGIB PHOSPHATE
|
1218778-77-8
|
|
Silmitasertib sodium salt
|
1309357-15-0
|
1309357-15-0
|
|
BML-284
|
WNT AGONIST 1 (CID11210285 盐酸盐)
|
853220-52-7
|
|
SAG hydrochloride
|
2095432-58-7
|
2095432-58-7
|
|
Porcn-IN-1
|
Porcupine-IN-1
|
2036044-77-4
|
|
ALLO-2
|
ALLO-2
(Smo inhibitor ALLO-2)
|
1357350-60-7
|
|
SR-3677
|
N-[2-[2-(二甲基氨基)乙氧基]-4-(1H-吡唑-4-基)苯基]-2,3-二氢-1,4-苯并二恶烷-2-甲酰胺
|
1072959-67-1
|
|
Vismodegib
|
维莫德吉
|
879085-55-9
|
|
Sonidegib
|
索尼吉布
|
956697-53-3
|
|
GSK269962A
|
N-[3-[[2-(4-氨基呋咱-3-基)-1-乙基-1H-咪唑并[4,5-C]吡啶-6-基]氧]苯基]-4-[[2-(4-吗啉基)乙基]氧]苯甲酰胺
|
850664-21-0
|
|
Ripasudil
|
(2S)-1-[(4-氟-5-异喹啉基)磺酰基]六氢-2-甲基-1H-1,4-二氮杂卓单盐酸盐二水合物
|
887375-67-9
|
|
JW74
|
JW74;JW 74
|
863405-60-1
|
|
ZINC00881524
|
557782-81-7
|
557782-81-7
|
|
DDR1-IN-2
|
DDR1-IN-2
|
1429617-90-2
|
|
MSAB
|
MSAB
|
173436-66-3
|
|
(E)-SIS3
|
SIS3
|
521984-48-5
|
|
GANT 58
|
4,44乔,4乔(2,3,4,5-Thiophentetrayl)tetrakis-pyridine
|
64048-12-0
|
|
Y-33075
|
(R)-4-(1-氨基乙基)-N-1H-吡咯并[2,3-B]吡啶-4-基苯甲酰胺
|
199433-58-4
|
|
PF-5274857
|
PF-5274857
|
1373615-35-0
|
|
Wnt-C59
|
PORCN酶活性和WNT抑制剂(WNT-C59)
|
1243243-89-1
|
|
iCRT3
|
CS-2716
|
901751-47-1
|
|
XMU-MP-1
|
XMU-MP-1
|
2061980-01-4
|
|
MK-4101
|
5-(3,3-二氟环丁基)-3-[4-[4-甲基-5-[2-(三氟甲基)苯基]-4H-1,2,4-三唑-3-基]双环[2.2.2]辛烷-1-基]-1,2,4-恶二唑
|
935273-79-3
|
|
KY1220
|
292168-79-7
|
292168-79-7
|
|
Pz-1
|
1800505-64-9
|
1800505-64-9
|
|
H-1152 dihydrochloride
|
871543-07-6
|
871543-07-6
|
|
NRX-252262
|
化合物NRX-252262
|
2438637-61-5
|
|
Ciliobrevin A
|
HPI-4
|
302803-72-1
|
|
LGK974
|
2',3-二甲基-N-[5-(2-吡嗪基)-2-吡啶基]-[2,4'-联吡啶]-5-乙酰胺
|
1243244-14-5
|
|
Ramucirumab
|
雷莫芦单抗
|
947687-13-0
|
|
SRI-011381 hydrochloride
|
SRI-011381 (hydrochloride)
|
2070014-88-7
|
|
Rho-Kinase-IN-1
|
Rho-Kinase-IN-1
|
1035094-83-7
|
|
Hydroxyfasudil
|
羟基法舒地尔
|
105628-72-6
|
|
Toxoflavin
|
毒黄素
|
84-82-2
|
|
XAV-939
|
3,5,7,8-四氢-2-[4-(三氟甲基)苯基]-4H-噻喃并[4,3-D]嘧啶-4-酮
|
284028-89-3
|
|
IWR-1
|
IWR-1
|
1127442-82-3
|
|
PNU-74654
|
PNU 74654,2-PHENOXYBENZOICACID-[(5-METHYL-2-FURANYL)METHYLENE]HYDRAZIDE
|
113906-27-7
|
|
WAY 316606
|
5-(苯磺酰基)-N-(哌啶-4-基)-2-(三氟甲基)苯磺酰胺
|
915759-45-4
|
|
HhAntag
|
N-[4-氯-3-[5-(二甲基氨基)-1H-苯并咪唑-2-基]苯基]-3,5-二甲氧基苯甲酰胺
|
496794-70-8
|
|
Glasdegib
|
格拉斯吉布
|
1095173-27-5
|
|
LH846
|
LH-846
|
639052-78-1
|
|
IWP-4
|
CS-2394
|
686772-17-8
|
|
KYA1797K
|
CS-2581
|
1956356-56-1
|
|
Glabrescione B
|
GLABRESCIONE B
|
65893-94-9
|
|
Dynarrestin
|
Dynarrestin
|
2222768-84-3
|
|
SSTC3
|
SSTC3
|
1242422-09-8
|
|
Cardiogenol C hydrochloride
|
2-[[2-[(4-甲氧基苯基)氨基]-4-嘧啶基]氨基]乙醇盐酸盐
|
1049741-55-0
|
|
TED-347
|
化合物TED-347
|
2378626-29-8
|
|
SAG
|
SAG
|
912545-86-9
|
|
ML-7 hydrochloride
|
1-(5-碘萘-1-磺酰基)-1H-六氢-1,4-二氮杂卓盐酸盐
|
110448-33-4
|
|
SB-772077B dihydrochloride
|
SB 772077B DIHYDROCHLORIDE
|
607373-46-6
|
|
iCRT 14
|
ICRT-14
|
677331-12-3
|
|
EMT inhibitor-1
|
FWMUIOJZHOPPDX-UHFFFAOYSA-N
|
1638526-21-2
|